Erick Gamelin

Insider Reports History

Entity
Individual
Location
C/O Acrivon Therapeutics, Inc., 480 Arsenal Way, Suite 100, Watertown, Massachusetts
Signature
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Erick Gamelin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Acrivon Therapeutics, Inc. Chief Development Officer Common Stock 17.4K $122K $7.02 Aug 14, 2024 Direct

Insider Reports Filed by Erick Gamelin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACRV Acrivon Therapeutics, Inc. Aug 14, 2024 1 -$2.82K 4 Aug 16, 2024 Chief Development Officer
ACRV Acrivon Therapeutics, Inc. May 14, 2024 1 -$3.36K 4 May 16, 2024 Chief Development Officer
ACRV Acrivon Therapeutics, Inc. Feb 14, 2024 1 -$1.59K 4 Feb 16, 2024 Chief Development Officer
ACRV Acrivon Therapeutics, Inc. Nov 14, 2023 1 -$7.09K 4 Nov 16, 2023 Chief Medical Officer
ACRV Acrivon Therapeutics, Inc. Nov 14, 2022 2 $0 4 Nov 16, 2022 Chief Medical Officer
ACRV Acrivon Therapeutics, Inc. Nov 9, 2022 0 $0 3 Nov 9, 2022 Chief Medical Officer